Support MEDICC and our global health equity projects.


Havana, December 12, 2016 – Almost 30 years since Cuba diagnosed its first case of HIV, the island’s National HIV/AIDS Program is showing results. Recent data from the Ministry of Public Health (MINSAP) reveal a...

MEDICC Review journal features an exclusive interview with the Director of Clinical Research of Cuba’s Molecular Immunology Center, home to innovative cancer vaccines and therapies, including CIMAvax for non-small cell lung cancer, recently cleared for U.S. clinical trials.